[144] IRADIMED CORP SEC Filing

Rhea-AI Filing Summary

Form 144 filed for IRADIMED CORP (IRMD) reports a proposed sale of 100,000 shares of common stock through Roth Capital Partners on 09/17/2025 with an aggregate market value of $7,076,000. The filing identifies the securities as held by the Phillip Susi 2008 Dynasty Trust, acquired on 01/01/1992, and indicates 2,362,500 shares were acquired by that trust on that date. The total shares outstanding reported in the filing are 12,720,002. The filer certifies there are no undisclosed material adverse facts known to the seller and states there were no sales in the past three months by the selling person.

Insights

Securities Analyst

TL;DR: An authorized Form 144 notice records a planned sale of 100,000 IRMD shares by a trust; size is below typical materiality thresholds.

The filing documents a Rule 144 notice for sale through Roth Capital Partners of 100,000 common shares valued at $7,076,000 based on the filers stated market value. The securities are held by the Phillip Susi 2008 Dynasty Trust and were originally acquired on 01/01/1992. With 12,720,002 shares outstanding, the proposed sale represents approximately 0.79% of outstanding shares, which is unlikely to be material to company capitalization on its own. The filer also affirms no undisclosed material adverse information and reports no sales in the prior three months.

Corporate Governance Expert

TL;DR: Routine insider/trust sale notice filed; disclosure appears complete for a Rule 144 transaction.

The document fulfills Rule 144 disclosure elements: identity of selling account, acquisition history, broker details, number of shares to be sold, approximate sale date, and a representation about material non-public information. The statement that no material adverse information is known is standard. There is no indication of accelerated selling or multiple recent disposals, as the form reports nothing to report for prior three-month sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Roth Capital Partners, LLC 888 San Clemente Drive Newport Beach CA 92660	100000	7076000	12720002	09/17/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/01/1992	Phillip Susi 2008 Dynasty Trust	Iradimed Corporation			2362500	01/01/1992	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the IRMD Form 144 disclose about the proposed sale?

The filing discloses a proposed sale of 100,000 shares of common stock via Roth Capital Partners on 09/17/2025 with an aggregate market value of $7,076,000.

Who is the selling holder in the IRMD Form 144?

The securities are reported as held by the Phillip Susi 2008 Dynasty Trust, acquired on 01/01/1992.

How large is the proposed sale relative to IRMD's outstanding shares?

The filing reports 12,720,002 shares outstanding; the proposed sale of 100,000 shares represents about 0.79% of outstanding shares.

Did the Form 144 report any sales in the prior three months?

The filing states "Nothing to Report" for securities sold during the past three months by the selling person.

What broker is handling the sale in the Form 144?

The broker listed is Roth Capital Partners, LLC at the Newport Beach, CA address provided.